Disease/Infection News

RSS

University of Leeds and WHO to create global strategy to prevent future pandemic threats

The University of Leeds has partnered with the World Health Organization to create a global strategy to protect populations against future threats such as the COVID-19 pandemic.

21 May 2021

Despite frequent vaccinations, COVID-19 could continue to cause recurrent waves and deaths

Covid-19 could continue to cause recurrent waves and deaths despite frequent vaccinations according to a new study from the University of East Anglia.

21 May 2021

Study analyzes the risk of other medical conditions after recovery from COVID-19

Researchers analyzed data from a large insurance company in the United States. They found an increased risk of other medical conditions after recovering from COVID-19 irrespective of pre-existing conditions or age.

21 May 2021

Metal complexes against coronavirus

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 3.42 million deaths worldwide. Despite the fact that there are vaccines for SARS-CoV-2, the emergence of new variants and the lack of adequate treatments have encouraged the search for new ways to combat this disease more effectively.

21 May 2021

Canopy Biosciences develops spatial proteomics assay for COVID-19

Canopy Biosciences, a Bruker Company, today announced the successful development of a new assay for examining immune response to COVID-19.

From Bruker Nano Surfaces and Metrology 21 May 2021

Study shows distinctive mutation in rapidly emerging SARS-CoV-2 B.1.1.7 sublineage

In a new study currently available on the medRxiv* preprint server, US researchers report the detection of a specific sub-lineage of B.1.1.7 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant harboring a novel S:D178H mutation and elucidate its transmission and evolutionary patterns.

21 May 2021

Total COVID-19 deaths in US counties have been underestimated by 20%, indicates study

Deaths caused by indirect effects of the pandemic emphasize the need for policy changes that address widening health and racial inequities.

21 May 2021

SARS-CoV-2 spike mutation can independently predict viral evolution

A team of scientists from Portugal has recently estimated the rate of mutation in two circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using experimental evolution methods. Their findings reveal that in a condition with no immune surveillance, SARS-CoV-2 can potentially undergo evolution during the first stages of infection. The study is currently available on the bioRxiv* preprint server.

21 May 2021

Study demonstrates the negative effects of HERV activation on human brain development

Since our ancestors infected themselves with retroviruses millions of years ago, we have carried elements of these viruses in our genes - known as human endogenous retroviruses, or HERVs for short.

21 May 2021

Survey assesses health care delays during COVID-19 outbreak

At the start of the COVID-19 outbreak, a University of Illinois Chicago researcher conducted a survey asking respondents if they experienced health care delays because of the pandemic. In addition to learning about the types of delays, the study also presented a unique opportunity to capture a historic moment at the pandemic's beginning.

21 May 2021

Researchers discover new coronavirus in East Malaysia

Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.

21 May 2021

Public sense of "collectivism" clearly predicts mask usage, shows study

Around the world and within the U.S., the percentage of people wearing masks during the Covid-19 pandemic has varied enormously. What explains this? A new study co-authored by an MIT faculty member finds that a public sense of "collectivism" clearly predicts mask usage, adding a cultural and psychological perspective to the issue.

21 May 2021

Researchers define immune determinants of protection against SARS-CoV-2 in mice

Researchers in the United States have conducted a preclinical study defining the roles that different arms of the immune system play in fighting primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as reinfection and infection following SARS-CoV-2 vaccination.

21 May 2021

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.

21 May 2021

Pfizer-BioNTech and Sinovac vaccines boost SARS-CoV-2 neutralizing responses

Researchers in the United States and Chile have provided preliminary evidence that individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – mount a robust neutralizing antibody response against the virus that can be significantly boosted by two doses of Sinovac Biotech’s CoronaVac vaccine or one dose of Pfizer-BioNTech’s BNT162b2 vaccine.

21 May 2021

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

Recently, a team of researchers from various countries analyzed the unique variants of S proteins across six continents, including Africa, Asia, Oceania, Europe, South America, and North America. They wanted to characterize the unique S protein variants embedded in SARS-CoV-2 genomes infecting millions of people globally.

20 May 2021

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers from the US and Denmark recently described a novel therapeutic option that targets the SARS-CoV-2 ribonucleic acid (RNA) using locked nucleic acid antisense oligonucleotides (LNA ASOs). They identified an LNA ASO that binds to the 5’ leader sequence of SARS-CoV-2 ORF1a/b. This disrupts a highly conserved stem-loop structure with nanomolar efficacy and inhibits viral replication in host cells.

20 May 2021

Researchers speculate the low prevalence of COVID-19 in Japan

Protective immune memory--through B cells, which make antibodies, and/or T cells, which in the case of CD8+ T cells can kill virus-infected cells--can be induced by identical but also by related viruses.

20 May 2021

COVID-19 death rate for people with IDD is higher across the U.S.

The COVID-19 death rate for people with intellectual and developmental disabilities (IDD) is higher than the general population in several states across the U.S., according to a new study published in Disability and Health Journal.

20 May 2021

Resuming global childhood vaccination campaigns during the COVID-19 pandemic

New research published on the medRxiv* preprint server suggests childhood vaccination to prevent other infectious diseases has plummeted during the pandemic. The decrease appears to stem from the suspension of health campaigns promoting immunization and the risk of catching the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).

20 May 2021

Disease/Infection News

University of Leeds and WHO to create global strategy to prevent future pandemic threats

Despite frequent vaccinations, COVID-19 could continue to cause recurrent waves and deaths

Study analyzes the risk of other medical conditions after recovery from COVID-19

Metal complexes against coronavirus

Canopy Biosciences develops spatial proteomics assay for COVID-19

Study shows distinctive mutation in rapidly emerging SARS-CoV-2 B.1.1.7 sublineage

Total COVID-19 deaths in US counties have been underestimated by 20%, indicates study

SARS-CoV-2 spike mutation can independently predict viral evolution

Study demonstrates the negative effects of HERV activation on human brain development

Survey assesses health care delays during COVID-19 outbreak

Researchers discover new coronavirus in East Malaysia

Public sense of "collectivism" clearly predicts mask usage, shows study

Researchers define immune determinants of protection against SARS-CoV-2 in mice

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Pfizer-BioNTech and Sinovac vaccines boost SARS-CoV-2 neutralizing responses

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers speculate the low prevalence of COVID-19 in Japan

COVID-19 death rate for people with IDD is higher across the U.S.

Resuming global childhood vaccination campaigns during the COVID-19 pandemic

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News